Bioactive Glass in the Treatment of Enamel White Spot Lesions
Phase 3
Completed
- Conditions
- White Spot Lesion of Tooth
- Interventions
- Drug: BiominFDrug: NovaminDrug: CPP-ACP
- Registration Number
- NCT04401280
- Lead Sponsor
- Rania Salah
- Brief Summary
the aim of this study is to evaluate the effectiveness of BiominF® and Novamin® in comparison to Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) in the treatment of enamel white spot lesions
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Not less than 1 white spot lesion on the labial surface of teeth in the anterior region with code 2 International Caries Detection and Assessment System II (ICDAS-II) or less
- Absence of any active periodontal disease.
- Written informed consent
Exclusion Criteria
- Known hypersensitivity/allergy to study products and/or materials used
- teeth having deep carious lesions or extensive restorations
- Unwillingness to be randomly assigned to 1 of the 3 treatment groups
- Advanced periodontal disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description BiominF® BiominF Test group Novamin® Novamin Test group CPP-ACP CPP-ACP Control group
- Primary Outcome Measures
Name Time Method Change in White spot lesions dimension 6 months: (Baseline, 1 week, 1 month, 3 months, 6 months) Quantified using computer-assisted analysis based on digital intraoral photographs
- Secondary Outcome Measures
Name Time Method change in lesion fluorescence 6 months: (Baseline, 1 week, 1 month, 3 months, 6 months) evaluated using diode laser fluorescence device (Diagnodent)
Trial Locations
- Locations (1)
Faculty of Dentistry
🇪🇬Alexandria, Egypt